These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital. Wiseman DN; Harrison J N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241 [TBL] [Abstract][Full Text] [Related]
23. Safety and efficacy of pharmacological thromboprophylaxis for hospitalized patients with cirrhosis: a single-center retrospective cohort study. Shatzel J; Dulai PS; Harbin D; Cheung H; Reid TN; Kim J; James SL; Khine H; Batman S; Whyman J; Dickson RC; Ornstein DL J Thromb Haemost; 2015 Jul; 13(7):1245-53. PubMed ID: 25955079 [TBL] [Abstract][Full Text] [Related]
25. Pharmacological Prophylaxis for Venous Thromboembolism Among Hospitalized Patients With Acute Medical Illness: An Electronic Medical Records Study. Rosenman M; Liu X; Phatak H; Qi R; Teal E; Nisi D; Liu LZ; Ramacciotti E Am J Ther; 2016; 23(2):e328-35. PubMed ID: 26720163 [TBL] [Abstract][Full Text] [Related]
26. Asian venous thromboembolism guidelines: prevention of venous thromboembolism. Liew NC; Chang YH; Choi G; Chu PH; Gao X; Gibbs H; Ho CO; Ibrahim H; Kim TK; Kritpracha B; Lee LH; Lee L; Lee WY; Li YJ; Nicolaides AN; Oh D; Pratama D; Ramakrishnan N; Robless PA; Villarama-Alemany G; Wong R; Int Angiol; 2012 Dec; 31(6):501-16. PubMed ID: 23222928 [TBL] [Abstract][Full Text] [Related]
27. Comparative effectiveness of low-molecular-weight heparin versus unfractionated heparin for thromboembolism prophylaxis for medical patients. Rothberg MB; Pekow PS; Lahti M; Lindenauer PK J Hosp Med; 2012; 7(6):457-63. PubMed ID: 22473716 [TBL] [Abstract][Full Text] [Related]
28. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention. Wu C; Alotaibi GS; Alsaleh K; Linkins LA; McMurtry MS Thromb Res; 2015 Feb; 135(2):243-8. PubMed ID: 25488466 [TBL] [Abstract][Full Text] [Related]
29. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients. Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080 [TBL] [Abstract][Full Text] [Related]
30. Unawareness of thromboprophylaxis is associated with low venous thromboembolism occurrence in hospitalized patients with acute inflammatory bowel disease flare. Sbeit W; Kadah A; Shafrir A; Kalisky I; Mahamid M; Hazou W; Katz L; Mari A; Khoury T Minerva Med; 2020 Dec; 111(6):560-565. PubMed ID: 32729705 [TBL] [Abstract][Full Text] [Related]
31. Effectiveness and safety of prophylactic anticoagulation among hospitalized patients with inflammatory bowel disease. Dawwas GK; Cuker A; Schaubel DE; Lewis JD Blood Adv; 2024 Mar; 8(5):1272-1280. PubMed ID: 38163322 [TBL] [Abstract][Full Text] [Related]
32. Safety of venous thromboembolism prophylaxis with fondaparinux in ischemic stroke. Hackett CT; Ramanathan RS; Malhotra K; Quigley MR; Kelly KM; Tian M; Protetch J; Wong C; Wright DG; Tayal AH Thromb Res; 2015 Feb; 135(2):249-54. PubMed ID: 25554497 [TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness analysis of doctor-pharmacist collaborative prescribing for venous thromboembolism in high risk surgical patients. Hale A; Merlo G; Nissen L; Coombes I; Graves N BMC Health Serv Res; 2018 Oct; 18(1):749. PubMed ID: 30285744 [TBL] [Abstract][Full Text] [Related]
34. Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a "real life" prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study). Depietri L; Marietta M; Scarlini S; Marcacci M; Corradini E; Pietrangelo A; Ventura P Intern Emerg Med; 2018 Jun; 13(4):527-534. PubMed ID: 29502330 [TBL] [Abstract][Full Text] [Related]
35. Venous thromboembolism in patients with inflammatory bowel diseases: a case-control study of risk factors. Scoville EA; Konijeti GG; Nguyen DD; Sauk J; Yajnik V; Ananthakrishnan AN Inflamm Bowel Dis; 2014 Apr; 20(4):631-6. PubMed ID: 24552828 [TBL] [Abstract][Full Text] [Related]
36. Anticoagulant therapy for venous thromboembolism in patients with inflammatory bowel disease. Lobo JL; Garcia-Fuertes JA; Trujillo-Santos J; Merah A; Blanco-Molina MÁ; Casado I; Hirmerova J; De Miguel J; Salgado E; Monreal M; Eur J Gastroenterol Hepatol; 2018 May; 30(5):526-530. PubMed ID: 29462026 [TBL] [Abstract][Full Text] [Related]
37. Thromboprophylaxis in adult and paediatric burn patients: A survey of practice in the United Kingdom. Vermaak PV; D'Asta F; Provins J; Farr M; Wilson YT Burns; 2019 Sep; 45(6):1379-1385. PubMed ID: 31079961 [TBL] [Abstract][Full Text] [Related]
38. Venous thromboembolism in lymphoma: how effectively are we treating patients? Muslimani AA; Spiro TP; Chaudhry AA; Taylor HC; Daw HA Am J Clin Oncol; 2009 Oct; 32(5):521-3. PubMed ID: 19546801 [TBL] [Abstract][Full Text] [Related]
39. Underutilization of anticoagulant for venous thromboembolism prophylaxis in three hospitals in Jakarta. Atmakusuma TD; Tambunan KL; Sukrisman L; Effendi S; Rachman A; Setiawati A; Rinaldi I; Mulansari NA; Rajabto W; Nasution SA; Muhadi ; Aninditha T; Sedono R; Sugiarto A; Pitoyo CW; Paramitha D; Astoro NW; Nasution IR Acta Med Indones; 2015 Apr; 47(2):136-45. PubMed ID: 26260556 [TBL] [Abstract][Full Text] [Related]
40. Lack of prophylaxis before the onset of acute venous thromboembolism among hospitalized cancer patients: the SWIss Venous ThromboEmbolism Registry (SWIVTER). Kucher N; Spirk D; Baumgartner I; Mazzolai L; Korte W; Nobel D; Banyai M; Bounameaux H Ann Oncol; 2010 May; 21(5):931-5. PubMed ID: 19828560 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]